Chart of the Day | FDA Reports Platinum-based Chemotherapy Drug Shortages; PFE, TEVA, PPLT

05/02/23 07:30AM EDT

Chart of the Day | FDA Reports Platinum-based Chemotherapy Drug Shortages; PFE, TEVA, PPLT - 2023.05.01 Chart of the Day

On Friday the FDA reported additions to the drug shortage list of Carboplatin injection, an oncology drug. Manufacturers including TEVA and PFE's Hospira unit cite increased demand. Carboplatin joins Cisplatin, another oncology drug for which shortages were reported in February.

We have cited excess mortality from cancer since early 2021 with drivers unknown. Certainly the lack of health care foregone is a significant part of the acceleration. Only 14% of cancers are detected through screening. The rest are diagnosed as a result of an unrelated encounter with the health care system or because symptoms arise. No health care services, no detection.

Regardless of the cause, shortages are likely to drive up cost of care. It is also likely to keep PPLT elevated. Companies do not anticipate a restoration of supply until 3Q 2023.

Let me know what you think.

Emily Evans
Managing Director – Health Policy


Twitter
LinkedIn

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.